{"name": "Forest Laboratories",
 "permalink": "forest-laboratories",
 "crunchbase_url": "http://www.crunchbase.com/company/forest-laboratories",
 "homepage_url": "http://www.frx.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "212-421-7850",
 "description": "",
 "created_at": "Wed Jun 09 04:48:41 UTC 2010",
 "updated_at": "Wed Feb 23 05:26:10 UTC 2011",
 "overview": "\u003Cp\u003EForest Laboratories, Inc. (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive difference in people\u0026#8217;s lives. In addition to its well-established franchises in therapeutic areas of the central nervous and cardiovascular systems, Forest\u0026#8217;s current pipeline includes product candidates in all stages of development and across a wide range of therapeutic areas. The Company is headquartered in New York, NY.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       16],
      "assets/images/resized/0008/9987/89987v1-max-150x150.jpg"],
     [[250,
       28],
      "assets/images/resized/0008/9987/89987v1-max-250x250.jpg"],
     [[328,
       37],
      "assets/images/resized/0008/9987/89987v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chairman \u0026 CEO",
    "person":
     {"first_name": "Howard",
      "last_name": "Solomon",
      "permalink": "howard-solomon",
      "image": null}},
   {"is_past": true,
    "title": "VP, Anti-infective Drug Development",
    "person":
     {"first_name": "James",
      "last_name": "Ge",
      "permalink": "james-ge",
      "image":
       {"available_sizes":
         [[[127,
            150],
           "assets/images/resized/0026/0286/260286v1-max-150x150.jpg"],
          [[150,
            176],
           "assets/images/resized/0026/0286/260286v1-max-250x250.jpg"],
          [[150,
            176],
           "assets/images/resized/0026/0286/260286v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Senior Medical Director",
    "person":
     {"first_name": "Noah",
      "last_name": "Rosenberg",
      "permalink": "noah-rosenberg",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [{"funding_round":
     {"round_code": "unattributed",
      "source_url": "http://www.ttpharma.com/PressReleases/2010/20100608TransTechPharmaInc/tabid/213/Default.aspx",
      "source_description": "ForestLaboratories and TransTech Pharma Enter Into License Agreement for the Development and Commercialization of Glucokinase Activators with Deal Valued at Up to $1.105 Billion",
      "raised_amount": 50000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2010,
      "funded_month": 6,
      "funded_day": 8,
      "company":
       {"name": "TransTech Pharma",
        "permalink": "transtech-pharma",
        "image":
         {"available_sizes":
           [[[150,
              57],
             "assets/images/resized/0008/9982/89982v1-max-150x150.jpg"],
            [[220,
              85],
             "assets/images/resized/0008/9982/89982v1-max-250x250.jpg"],
            [[220,
              85],
             "assets/images/resized/0008/9982/89982v1-max-450x450.jpg"]],
          "attribution": null}}}},
   {"funding_round":
     {"round_code": "unattributed",
      "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020121022e8amupu64\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020121022e8amupu64%26from%3dalert%26pid%3d32",
      "source_description": "Forest Laboratories to Provide $125M to Moksha8 in Financing with Buyout Option",
      "raised_amount": 125000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2012,
      "funded_month": 10,
      "funded_day": 22,
      "company":
       {"name": "moksha8 Pharmaceuticals",
        "permalink": "moksha8-pharmaceuticals",
        "image":
         {"available_sizes":
           [[[150,
              57],
             "assets/images/resized/0010/5964/105964v1-max-150x150.jpg"],
            [[181,
              69],
             "assets/images/resized/0010/5964/105964v1-max-250x250.jpg"],
            [[181,
              69],
             "assets/images/resized/0010/5964/105964v1-max-450x450.jpg"]],
          "attribution": null}}}},
   {"funding_round":
     {"round_code": "c",
      "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020130509e959nao4z\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020130509e959nao4z%26from%3dalert%26pid%3d32",
      "source_description": "Trevena Raises $60M Series C, Strikes $430M Option Deal With Forest L",
      "raised_amount": 60000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2013,
      "funded_month": 5,
      "funded_day": 9,
      "company":
       {"name": "Trevena",
        "permalink": "trevena",
        "image":
         {"available_sizes":
           [[[135,
              79],
             "assets/images/resized/0004/9263/49263v1-max-150x150.jpg"],
            [[135,
              79],
             "assets/images/resized/0004/9263/49263v1-max-250x250.jpg"],
            [[135,
              79],
             "assets/images/resized/0004/9263/49263v1-max-450x450.jpg"]],
          "attribution": null}}}}],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "909 Third Avenue",
    "address2": "",
    "zip_code": "10022",
    "city": "New York",
    "state_code": "NY",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Forest Labs to acquire Clinical Data for $1.2 billion",
    "stoned_year": 2011,
    "stoned_month": 2,
    "stoned_day": 22,
    "source_url": "http://www.reuters.com/article/2011/02/22/us-forest-clinicaldata-idUSTRE71L3N420110222",
    "source_text": "",
    "source_description": "Forest Labs to acquire Clinical Data for $1.2 billion",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Forest Laboratories",
      "permalink": "forest-laboratories"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        95],
       "assets/images/resized/0012/3496/123496v1-max-150x150.jpg"],
      [[250,
        159],
       "assets/images/resized/0012/3496/123496v1-max-250x250.jpg"],
      [[450,
        287],
       "assets/images/resized/0012/3496/123496v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}